S 2580 requires licensed healthcare providers (including doctors, nurses, and midwives) to conduct regular screenings for intimate partner violence during patient visits, using private settings or telehealth options. If abuse is suspected, providers must document findings, immediately provide patients with local resources and referrals, and ensure patients reapprove who can access their medical records - preventing perpetrators from obtaining copies. This directly affects healthcare facilities and patients experiencing abuse by current or former partners. Key provisions include mandatory screening documentation, resource lists maintained by state departments, and same-visit interventions to protect victims' medical privacy.
This bill requires New Jersey's Department of Health (DOH) to launch a mobile cancer screening program within 180 days of its effective date. The program will use staffed mobile vehicles deployed across the state's northern, central, and southern regions, each operated by at least one qualified healthcare professional who determines screening methods based on their expertise and available equipment. The bill appropriates $100,000 from the state General Fund to fund this initiative and mandates a report to the Governor and Legislature within two years, summarizing results and suggesting future legislative action. The program directly affects New Jersey residents, particularly those in underserved areas who may gain easier access to cancer screenings.
S 569 establishes a three-year County-Based School Security Pilot Program in Essex, Mercer, and Camden counties, directly affecting public school students and districts in those areas. The bill provides $15 million from the General Fund to fund two key components: county-based mental health services (including screenings, counseling, and crisis intervention) and enhanced school security infrastructure (such as active shooter training and bullet-resistant shields). The program requires collaboration between the Education Department and other state agencies, with annual reports to the Governor and Legislature evaluating the pilot's effectiveness. This initiative aims to address student mental health needs and physical security in participating school districts through concrete, funded provisions.
This bill (S 1096) requires local health boards in New Jersey to mandate a minimum indoor temperature of 70 degrees Fahrenheit from October through April in specific buildings housing seniors (62+ years) and disabled individuals. It directly affects "housing for older persons" (per federal Fair Housing Act) and community residences for developmentally disabled, mentally ill, or head-injured persons - excluding nursing facilities already meeting federal temperature standards. The key provision amends existing law to raise the required temperature from 68°F to 70°F during cold months, applying when building owners agree to supply heat. This policy change focuses on setting a concrete thermal standard to protect vulnerable residents during winter.
S 2571 establishes a New Jersey task force within the Department of Health to study the health care needs of LGBTQI+ individuals (including those with intersex conditions) and develop recommendations. The task force will review current policies, resources, and barriers to care - such as discrimination and gaps in medical training - and examine medical education to improve health care access and quality. It must submit its recommendations to the Governor and Legislature within one year of formation. This initiative directly addresses documented health disparities, including higher rates of mental health issues and barriers to insurance coverage faced by LGBTQI+ residents.
This bill establishes a new Medicaid Managed Care Organization (MCO) Oversight Program to improve access and quality of care for Medicaid and NJ FamilyCare enrollees in New Jersey. It requires MCOs (the private insurers contracted to provide health services) to submit quarterly data on providers and beneficiaries, and mandates annual verification that 20% of provider contact information and online directory listings are accurate. MCOs must also confirm all directory providers are Medicaid-eligible and that provider panel sizes comply with state limits. Non-compliant MCOs face fines of at least $50,000 per violation and potential exclusion from the program for up to five years, with annual oversight reports to the Legislature.
This bill requires health insurance companies in New Jersey to allow any licensed clinical laboratory to join their provider network for covered lab services under the same terms and conditions offered to other participating labs. It directly affects licensed clinical laboratories that provide services covered by health insurance plans. The key provision prohibits insurers from denying participation based on the lab's specific licensing or network status, ensuring equal access for qualified providers. The Commissioner of Banking and Insurance will develop implementing rules to enforce this requirement.
This bill requires New Jersey Medicaid to pay hospice programs the same rate for inpatient room and board services as it pays nursing homes for similar care. It directly affects licensed hospice providers and nursing homes participating in the state's Medicaid program. The key provision mandates that reimbursement rates for hospice inpatient room/board (under Section 20(b)) must equal those for nursing home residents receiving hospice services. This change applies specifically to inpatient hospice units, excluding home-based care and certain federal-covered days. The bill aims to align payment structures without altering existing hospice service coverage.
This bill (S 1386) allows multiple independent health care providers in New Jersey to jointly negotiate with insurance carriers (health/dental plans) about non-fee-related policies affecting patient care. It directly affects licensed health care providers (like doctors and dentists) who practice in the same service area as a carrier, enabling them to form groups to discuss clinical policies rather than just payment rates. Key provisions cover topics such as medical necessity rules, referral standards, drug formularies, and utilization management (how insurers review care decisions). The goal is to give providers more negotiating power to improve care quality and access, countering carriers' current ability to unilaterally set terms. The bill aims to restore market balance while qualifying these joint negotiations for legal protection under antitrust laws.
This bill prohibits health insurance carriers (like major insurance companies) from obtaining or renewing licenses to operate as pharmacy benefits managers (PBMs). PBMs are entities that manage prescription drug programs for insurers, and this law specifically blocks insurers from holding these licenses. The bill amends existing licensing rules to require PBMs to meet strict standards for conflicts of interest, anti-competitive practices, and consumer protection, but explicitly bars health insurance carriers from applying for or maintaining such licenses. It does not affect existing PBM licenses held by non-insurer entities.
